78 related articles for article (PubMed ID: 27180197)
41.
Kucherenko AM; Pampukha VM; Romanchuk KY; Chernushyn SY; Bobrova IA; Moroz LV; Livshits LA
Cytol Genet; 2016; 50(5):330-333. PubMed ID: 32214544
[TBL] [Abstract][Full Text] [Related]
42. Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera.
Jäger R; Gisslinger H; Fuchs E; Bogner E; Milosevic Feenstra JD; Weinzierl J; Schischlik F; Gisslinger B; Schalling M; Zörer M; Krejcy K; Klade C; Kralovics R
Blood; 2021 Jan; 137(3):387-391. PubMed ID: 32814349
[TBL] [Abstract][Full Text] [Related]
43. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
44. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
[TBL] [Abstract][Full Text] [Related]
45.
Rugwizangoga B; Andersson ME; Kabayiza JC; Nilsson MS; Ármannsdóttir B; Aurelius J; Nilsson S; Hellstrand K; Lindh M; Martner A
Front Cell Infect Microbiol; 2019; 9():340. PubMed ID: 31637221
[TBL] [Abstract][Full Text] [Related]
46. Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers.
Jenkins FJ; Minas TZ; Tang W; Dorsey TH; Ambs S
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):338-346. PubMed ID: 35468990
[TBL] [Abstract][Full Text] [Related]
47. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
Fang MZ; Jackson SS; Pfeiffer RM; Kim EY; Chen S; Hussain SK; Jacobson LP; Martinson J; Prokunina-Olsson L; Thio CL; Duggal P; Wolinsky S; O'Brien TR
Clin Infect Dis; 2023 Feb; 76(3):521-527. PubMed ID: 36573283
[TBL] [Abstract][Full Text] [Related]
48. Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.
Vergara C; Duggal P; Thio CL; Valencia A; O'Brien TR; Latanich R; Timp W; Johnson EO; Kral AH; Mangia A; Goedert JJ; Piazzola V; Mehta SH; Kirk GD; Peters MG; Donfield SM; Edlin BR; Busch MP; Alexander G; Murphy EL; Kim AY; Lauer GM; Chung RT; Cramp ME; Cox AL; Khakoo SI; Rosen HR; Alric L; Wheelan SJ; Wojcik GL; Thomas DL; Taub MA
Genes Immun; 2020 Nov; 21(5):348-359. PubMed ID: 33116245
[TBL] [Abstract][Full Text] [Related]
49. IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children.
Prokunina-Olsson L; Morrison RD; Obajemu A; Mahamar A; Kim S; Attaher O; Florez-Vargas O; Sidibe Y; Onabajo OO; Hutchinson AA; Manning M; Kwan J; Brand N; Dicko A; Fried M; Albert PS; Mbulaiteye SM; Duffy PE
Genes Immun; 2021 May; 22(1):44-55. PubMed ID: 33850301
[TBL] [Abstract][Full Text] [Related]
50.
Tang W; Wallace TA; Yi M; Magi-Galluzzi C; Dorsey TH; Onabajo OO; Obajemu A; Jordan SV; Loffredo CA; Stephens RM; Silverman RH; Stark GR; Klein EA; Prokunina-Olsson L; Ambs S
Clin Cancer Res; 2018 Nov; 24(21):5471-5481. PubMed ID: 30012562
[No Abstract] [Full Text] [Related]
51. Distribution of
Sorrentino L; Silvestri V; Oliveto G; Scordio M; Frasca F; Fracella M; Bitossi C; D'Auria A; Santinelli L; Gabriele L; Pierangeli A; Mastroianni CM; d'Ettorre G; Antonelli G; Caruz A; Ottini L; Scagnolari C
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208821
[TBL] [Abstract][Full Text] [Related]
52.
Meza G; Galián F; Jaimes-Bernal C; Márquez FJ; Sinangil F; Scagnolari C; Real LM; Forthal D; Caruz A
Virulence; 2022 Dec; 13(1):757-763. PubMed ID: 35481423
[TBL] [Abstract][Full Text] [Related]
53.
Minas TZ; Tang W; Smith CJ; Onabajo OO; Obajemu A; Dorsey TH; Jordan SV; Obadi OM; Ryan BM; Prokunina-Olsson L; Loffredo CA; Ambs S
Commun Biol; 2018; 1():191. PubMed ID: 30456312
[TBL] [Abstract][Full Text] [Related]
54. Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study.
Zahid W; Farooqui N; Zahid N; Ahmed K; Anwar MF; Rizwan-Ul-Hasan S; Hussain AR; Sarría-Santamera A; Abidi SH
Infect Drug Resist; 2023; 16():6619-6628. PubMed ID: 37840831
[TBL] [Abstract][Full Text] [Related]
55. CCR5-Δ32 and IFNL4-ΔG/TT.
Jiang JJ; Fang MZ; Jackson SS; O'Brien TR
Clin Ther; 2019 Dec; 41(12):2658-2659. PubMed ID: 31711627
[No Abstract] [Full Text] [Related]
56. Some concerns about "PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases".
Liu Y
Liver Int; 2021 May; 41(5):1154. PubMed ID: 33058503
[No Abstract] [Full Text] [Related]
57. Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?
Galmozzi E; D'Ambrosio R
Hepatobiliary Surg Nutr; 2018 Jun; 7(3):209-211. PubMed ID: 30046576
[No Abstract] [Full Text] [Related]
58. Hepatitis: New gene IFNL4 is associated with impaired clearance of HCV.
Ray K
Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):63. PubMed ID: 23338061
[No Abstract] [Full Text] [Related]
59. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
60. Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon/ribavirin therapy: A meta-analysis.
Xie X; Zhang L; Chen YZ
Hum Immunol; 2016 Jul; 77(7):609-15. PubMed ID: 27180197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
